Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To examine the safety and efficacy of cangrelor in patients with single-vessel disease (SVD) and multi-vessel disease (MVD).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. Heart J.

Title: American heart journal

Publisher: Elsevier BV

ISSN (Electronic): 1097-6744

ISSN (Print): 0002-8703

Publication date (Electronic): Jun 2017

Volume: 188

Affiliations

[1 ] Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA.

[2 ] Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA.

[3 ] The Medicines Company, Parsippany, NJ.

[4 ] Columbia University Medical Center and the Cardiovascular Research Foundation, NY, New York.

[5 ] Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.

[6 ] DHU (Département Hospitalo-Universitaire)-FIRE (Fibrosis, Inflammation, REmodelling), Hôpital Bichat, AP-HPb (Assistance Publique-Hôpitaux de Paris), Université Paris-Diderot, Sorbonne-Paris Cité, and FACT (French Alliance for Cardiovascular clinical Trials), an F-CRIN network, INSERM U-1148, Paris, France; NLHI, ICMS, Royal Brompton Hospital, Imperial College, London, United Kingdom.

[7 ] Beth Israel Deaconess Medical Center, Division of Cardiology, Harvard Medical School Boston, Boston, MA.

[8 ] University of Auckland, Auckland City Hospital, Auckland, New Zealand.

[9 ] Scripps Clinic and Scripps Translational Science Institute, La Jolla, CA.

[10 ] Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA.

[11 ] Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA. Electronic address: Kenneth.Mahaffey@stanford.edu.

Article

Publisher Item ID: S0002-8703(17)30079-0

DOI: 10.1016/j.ahj.2017.02.031

PubMed ID: 28577670

SO-VID: 177363d5-bf4f-4a54-aa60-135c6253f802

History

Data availability:

Comments

Comment on this article

scite_

Cited by 2

See all cited by